Azathioprine induced pancytopenia: A serious complication

Journal of Postgraduate Medicine

Volumn 55, Issue 2, 2009, Pages 139-140

  Hadda, V ^a   Pandey, B D ^a   Gupta, R ^a   Goel, A ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Azathioprine; Lupus nephritis; Pancytopenia; Systemic lupus erythematosus

Indexed keywords

AMLODIPINE; ANTIBIOTIC AGENT; ATENOLOL; AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; ENALAPRIL; FUROSEMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; UREA;

ADULT; ARTICLE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEBRILE NEUTROPENIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MALE; PANCYTOPENIA; PATIENT MONITORING; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AZATHIOPRINE; DRUG TOXICITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; MALE; PANCYTOPENIA; TREATMENT OUTCOME;

EID: 67651180616     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.52849     Document Type: Article

References (11)

1. Telm A, Schaeffeler E, Herlinger KR, Klotz U, Schwab M. Thiopurine treatment in inflammatory bowel disease. Clin Pharmacokinet 2007;46:187-208.
2. Konstantopoulou M, Belgi A, Griffiths KD, Seale JRC, MacFarlane AW. Azathioprine induced pacytopenia in a patients with pompholyx and deficiency of erythrocyte thiopurine methyltransferase. BMJ 2005;330:350-2.
3. Nossent JC, Swaak AJ. Pancytopenia in systemic lupus erythematosus related to azathioprine. J Intern Med 1990;227:69-72.
4. Colombel J F, Ferrari N, Debuysere H, Marteau P, Gendre J P, Bonaz B, et al. Genotypic analysis of thiopurine S- methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroentrology 2000;118:1025-30.
5. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980:32:651-62.
6. Holme SA, Duley JA, Sanderson J, Routledge PA, Anstey A. Erythrocyte thiopurine methyltransferase assessment prior to azathioprine use in the UK. Q J Med 2002;95:439-44.
7. Gardiner SJ, Begg EJ. Pharmacogenetics testing for drug mssetabolizing enzymes: Is it happening in practice? Pharmacogen Genomics 2005;15:365-9.
8. Seidman EG. Clinical use and practical application of TPMT enzyme and 6- meraptopurine metabolite monitoring in IBD. Rev Gastroenterol Dis 2003;3:S30-8.
9. Kham SK, Tan PL, Tay AH, Heng CK, Yeoh AE, Quah TC. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia. Pharmacogenetics 2002;12:191-5.
10. Misra R, Sharma BL, Gupta R, Pandya S, Agarwal S, Agarwal P, et al. Indian Rheumatology Association consensus statement on management of adults with rheumatoid arthritis. Indian J Rheumatol 2008;3:S1-16.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.